Get the Daily Brief
Latest Biotech News
FDA Approves Eli Lilly’s Oral SERD Inluriyo for Advanced Breast Cancer
Eli Lilly’s oral selective estrogen receptor degrader (SERD) Inluriyo (imlunestrant) received FDA approval for treating metastatic estrogen receptor-positive, HER2-negative breast cancer in...
Breakthrough Bridge Recombinase Technology Enables Massive Human Genome Editing
Researchers at the Arc Institute have developed programmable bridge recombinase systems capable of megabase-scale DNA rearrangements in human cells. This technology allows large-scale gene...
Unprecedented AI-Driven Nanoparticle Design Platform Emerges from Duke University
Biomedical engineers at Duke University have integrated automated wet lab techniques with sophisticated artificial intelligence to revolutionize the design of nanoparticles for targeted drug...
Crinetics Pharmaceuticals Gains FDA Nod for Acromegaly Drug Amid Competition
Crinetics Pharmaceuticals earned FDA approval for Palsonify, an oral once-daily treatment for acromegaly in adults ineligible for or unresponsive to surgery. Clinical trials demonstrated...
UniQure’s AMT-130 Gene Therapy Nears First Approval for Huntington’s Disease
Following the pivotal Phase I/II study results showcasing a 75% slowdown in Huntington’s disease progression, UniQure is preparing to seek FDA approval for its gene therapy AMT-130 in early 2026....
Lila Sciences Raises $235M to Propel AI-Driven Scientific Discovery
Lila Sciences secured $235 million in a Series A funding round to develop its AI-powered platform aimed at accelerating drug development by integrating generative AI, robotics, and automated...
Hansa Biopharma’s Imlifidase Shows Success in Phase III Kidney Transplant Trial
Hansa Biopharma reported positive results from a pivotal Phase III trial of imlifidase, an antibody-cleaving enzyme that enables highly sensitized kidney patients to receive transplants. The trial...
STAT+ Reports UK Embraces mRNA Biotech as U.S. Pulls Back Funding
UK officials and researchers are positioning the country as a hub for mRNA-based biotechnology, highlighted by Moderna’s new facility and government support. This contrasts with recent U.S. policy...
STAT+: Uniqure’s Huntington’s Gene Therapy Marks Breakthrough Progress
UniQure’s investigational gene therapy, AMT-130, achieved a 75% reduction in disease progression for Huntington’s disease after three years, representing the most compelling data in the field so...
Unprecedented Gene Therapy Success Slows Huntington’s Disease Progression
UniQure NV announced promising Phase I/II clinical trial results for its gene therapy AMT-130 targeting Huntington’s disease, demonstrating a significant 75% slowing in disease progression after...
Acadia Pharma Halts Prader-Willi Drug After Phase III Failure
Acadia Pharmaceuticals discontinued development of ACP-101, an intranasal therapy aimed at mitigating hyperphagia in patients with Prader-Willi syndrome (PWS), after its 12-week phase III trial...
AI Advances Propel Drug Discovery and Cancer Immunotherapy
Multiple high-impact breakthroughs demonstrate artificial intelligence’s growing role in biopharma innovation. The Arc Institute’s Germinal platform couples AlphaFold-Multimer structural...
FDA Issues Setbacks and Strategic Shifts in Biopharma Pipeline
The FDA posed a complete response letter to Biogen for a high-dose formulation of Spinraza demanding more manufacturing data, underscoring regulatory scrutiny in spinal muscular atrophy treatment...
Novel Biomarkers and Diagnostic Tools Emerging in Oncology and Infectious Diseases
Recent studies introduce cutting-edge molecular tools and biomarkers expanding diagnostic and therapeutic precision. A gene panel predicting response to CDK4/6 inhibitors in breast cancer could...
Breakthroughs in Regenerative Medicine and Cell Therapy Platforms
Multiple innovations promise to transform regenerative treatments. A novel engineered biphasic scaffold has been developed to promote bone regeneration without growth factors, marking a potential...
Major Step in Pandemic Preparedness and Infectious Disease Surveillance
The University of Ottawa secured $3 million federal funding to lead infectious disease research enhancing Canada’s readiness for future pandemics. Similarly, the Global Virus Network initiated a...
Cancer Research Yields New Molecular Targets and Therapies
Cutting-edge research reveals molecular insights that may translate into improved cancer treatments. Studies show that deletion of the Trp53 gene promotes immune evasion and tumor progression in...
Innovations in AI and Robotics Enhance Healthcare and Biotech Research
Advances in artificial intelligence and robotic technologies are reshaping biomedical research and healthcare delivery. Virginia Tech researchers developed an efficient method to separate...
uniQure’s Gene Therapy Slows Huntington’s Disease by 75% in Phase I/II Trial
UniQure has reported groundbreaking results from its pivotal Phase I/II study of AMT-130 gene therapy for Huntington’s disease, demonstrating a 75 percent slowing of disease progression at 36...
Acadia Pharma Terminates Phase III Prader-Willi Syndrome Drug Development
Acadia Pharmaceuticals announced the discontinuation of its investigational intranasal carbetocin (ACP-101) following a failed Phase III clinical trial to treat hyperphagia in patients with...